Primary bacterial infectious disease
MONDO:0000314590 clinical trials for this condition and its sub-types, 0 tagged with Primary bacterial infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Primary bacterial infectious disease
-
Tuberculosis 216 trials · 298 incl. sub-types
12 sub-types
- Pulmonary tuberculosis 107 trials · 110 incl. sub-types Sub-types →
- Latent tuberculosis infection 72 trials
- Drug-resistant tuberculosis 9 trials · 40 incl. sub-types Sub-types →
- Extrapulmonary tuberculosis 6 trials · 28 incl. sub-types Sub-types →
- Active tuberculosis 23 trials
- Tuberculous encephalopathy 1 trial
- Endocrine tuberculosis 0 trials Sub-types →
- Multifocal tuberculosis 0 trials
- Primary bone and joint tuberculosis 0 trials
- Primary tuberculosis of the digestive system 0 trials
- Primary tuberculous lymphadenitis 0 trials
- Tuberculoma 0 trials
-
Syphilis 47 trials · 56 incl. sub-types
10 sub-types
- Congenital syphilis 7 trials Sub-types →
- Primary syphilis 7 trials
- Yaws 3 trials · 4 incl. sub-types Sub-types →
- Latent syphilis 1 trial · 2 incl. sub-types Sub-types →
- Tertiary syphilis 0 trials · 2 incl. sub-types Sub-types →
- Secondary syphilis 1 trial
- Bejel 0 trials
- Chancre 0 trials
- Cutaneous syphilis 0 trials Sub-types →
- Syphilitic aortitis 0 trials
-
Gonorrhea 49 trials
12 sub-types
- Gonococcal bursitis 0 trials
- Gonococcal cervicitis 0 trials Sub-types →
- Gonococcal conjunctivitis 0 trials Sub-types →
- Gonococcal cystitis 0 trials Sub-types →
- Gonococcal endophthalmia 0 trials Sub-types →
- Gonococcal epididymo-orchitis 0 trials Sub-types →
- Gonococcal infection of joint 0 trials Sub-types →
- Gonococcal prostatitis 0 trials Sub-types →
- Gonococcal salpingitis 0 trials Sub-types →
- Gonococcal seminal vesiculitis 0 trials Sub-types →
- Gonococcal spondylitis 0 trials
- Gonococcal urethritis 0 trials
-
Tetanus 43 trials
1 sub-type
- Tetanus neonatorum 0 trials
-
Lyme disease 30 trials
-
Diphtheria 27 trials
7 sub-types
- Anterior nasal diphtheria 0 trials
- Cutaneous diphtheria 0 trials
- Diphtheritic myocarditis 0 trials
- Faucial diphtheria 0 trials
- Laryngeal diphtheria 0 trials
- Nasopharyngeal diphtheria 0 trials
- Pseudomembranous diphtheritic conjunctivitis 0 trials
-
Mycobacterium avium complex disease 22 trials
-
Anthrax infection 17 trials · 20 incl. sub-types
4 sub-types
- Inhalational anthrax 4 trials
- Injection anthrax 3 trials
- Cutaneous anthrax 2 trials
- Gastrointestinal anthrax 2 trials Sub-types →
-
Salmonellosis 5 trials · 19 incl. sub-types
5 sub-types
- Typhoid fever 14 trials
- Invasive non-typhoidal salmonellosis 5 trials
- Salmonella gastroenteritis 0 trials
- Paratyphoid fever 0 trials
- Salmonella discitis 0 trials
-
Cholera 16 trials
-
Shigellosis 14 trials
-
Leprosy 11 trials · 12 incl. sub-types
6 sub-types
- Lepromatous leprosy 3 trials
- Multibacillary leprosy 3 trials
- Borderline leprosy 0 trials
- Indeterminate leprosy 0 trials
- Paucibacillary leprosy 0 trials
- Tuberculoid leprosy 0 trials
-
Leptospirosis 9 trials
1 sub-type
- Weil's disease 0 trials
-
Botulism 5 trials
4 sub-types
- Foodborne botulism 0 trials
- Iatrogenic botulism 0 trials
- Inhalational botulism 0 trials
- Toxin-mediated infectious botulism 0 trials Sub-types →
-
Listeriosis 4 trials
1 sub-type
- Listeria meningitis 0 trials
-
Plague 2 trials · 4 incl. sub-types
3 sub-types
- Pneumonic plague 3 trials
- Bubonic plague 1 trial
- Septicemic plague 0 trials
-
Buruli ulcer disease 3 trials
-
Q fever 3 trials
-
Campylobacteriosis 3 trials
1 sub-type
-
Melioidosis 3 trials
-
Brucellosis 2 trials
4 sub-types
- Brucella abortus brucellosis 0 trials
- Brucella canis brucellosis 0 trials
- Brucella melitensis brucellosis 0 trials
- Brucella suis brucellosis 0 trials
-
Relapsing fever 2 trials
2 sub-types
- Louse-borne relapsing fever 0 trials
- Tick-borne relapsing fever 0 trials
-
Legionellosis 1 trial · 2 incl. sub-types
2 sub-types
- Legionnaires' disease 2 trials
- Pontiac fever 0 trials
-
Ehrlichiosis 1 trial
1 sub-type
- Human monocytic ehrlichiosis 0 trials
-
Ornithosis 1 trial
-
Pinta disease 1 trial
-
Bartonellosis 0 trials · 1 incl. sub-types
4 sub-types
- Cat-scratch disease 1 trial
- Oroya fever 0 trials Sub-types →
- Bacillary angiomatosis 0 trials
- Trench fever 0 trials
-
Granuloma inguinale 0 trials · 1 incl. sub-types
1 sub-type
- Lymphogranuloma venereum 1 trial
-
Borrelia miyamotoi disease 0 trials
-
Chancroid 0 trials
-
Glanders 0 trials
-
Rhinoscleroma 0 trials
-
Sennetsu fever 0 trials
-
Spirillary rat-bite fever 0 trials
-
Staphyloenterotoxemia 0 trials
-
Streptobacillary rat-bite fever 0 trials
-
Tularemia 0 trials
6 sub-types
- Gastrointestinal tularemia 0 trials
- Glandular tularemia 0 trials
- Oculoglandular tularemia 0 trials
- Pneumonic tularemia 0 trials
- Typhoidal tularemia 0 trials
- Ulceroglandular tularemia 0 trials
Most studied deeper sub-types
-
Supercharged immune cells take on Drug-Resistant infections
Disease control Stopped earlyThis trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant …
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a 3-Month TB cocktail replace the standard 6-Month regimen?
Disease control Stopped earlyThis clinical trial investigates whether a 3-month combination of clofazimine and rifapentine can effectively treat drug-susceptible tuberculosis (TB) compared to the standard 6-month regimen. The study includes adults with pulmonary TB, some of whom also have HIV. Researchers ar…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for stubborn lung infection? trial of epetraborole begins, then stops
Disease control Stopped earlyThis study tested an oral drug called epetraborole for people with a tough-to-treat lung infection called MAC lung disease. The trial aimed to see if adding epetraborole to standard treatment could improve symptoms and clear the infection. However, the study was terminated early,…
Phase 2/3 • Sponsor: AN2 Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could aspirin or ibuprofen help beat TB faster?
Disease control Stopped earlyThis study tested whether adding aspirin or ibuprofen to standard tuberculosis (TB) treatment helps patients recover more quickly. It included 426 adults with drug-sensitive or drug-resistant TB. The trial was terminated early, so the results are not conclusive.
Phase 2 • Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New TB drug cocktails aim to cut treatment time in half
Disease control Stopped earlyThis clinical trial tested whether combining several drugs—bedaquiline, OPC-167832, sutezolid, and either pretomanid or delamanid—could treat pulmonary tuberculosis in just 2 to 4 months instead of the standard 6 months. The study enrolled 93 adults with drug-sensitive or drug-re…
Phase 2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New syphilis combo treatment tested in HIV patients – trial cut short
Disease control Stopped earlyThis study looked at two different antibiotic combinations for treating early syphilis in people living with HIV. One group received a single shot of ceftriaxone plus a week of doxycycline pills, while the other got the standard single shot of penicillin plus the same doxycycline…
Phase 4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New inhaled drug aimed at stubborn lung infection shows promise, but trial halted early
Disease control Stopped earlyThis phase 3 study tested an inhaled form of the antibiotic clofazimine added to standard therapy for people with MAC lung disease that did not respond to previous treatment. The goal was to see if the drug could clear the infection from sputum cultures and improve quality of lif…
Phase 3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
TB prevention study halted early – only 16 volunteers enrolled
Prevention Stopped earlyThis study aimed to see if a single dose of the BCG vaccine could prevent tuberculosis infection in healthy adults traveling to countries with high TB rates. Participants were randomly assigned to receive either BCG or a placebo. The study was terminated early and enrolled only 1…
Phase 3 • Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Lyme arthritis pain study halted early – what we know
Symptom relief Stopped earlyThis study aimed to see if taking NSAIDs (like naproxen) on a regular schedule could reduce arthritis symptoms and prevent long-term joint problems in people with Lyme disease. Only 3 participants were enrolled before the study was stopped, so no clear conclusions can be drawn. T…
Phase 3 • Sponsor: Desiree Neville, MD • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Pregnancy drug study aims to protect moms and babies from HIV and TB
Knowledge-focused Stopped earlyThis study looked at how HIV and tuberculosis (TB) medications are processed in the bodies of pregnant women and new mothers. Researchers measured drug levels in the blood of 205 women during pregnancy and after delivery to see if standard doses are effective. The goal was to gat…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC